Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Presta

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
International Journal of Molecular Sciences|July 14, 2023
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma CellsDavide Capoferri, Paola Chiodelli, Marzia Corli, et al.
Molecular Cancer Therapeutics|October 17, 2013
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cellsRoberto Ronca, Emanuela Di Salle, Arianna Giacomini, et al.
Oncotarget|May 14, 2016
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonistElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Journal of Cellular and Molecular Medicine|July 25, 2009
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptideDaria Leali, Roberta Bianchi, Antonella Bugatti, et al.
Molecular Cancer Research : MCR|March 11, 2010
The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivoJo Vandercappellen, Sandra Liekens, Annelies Bronckaers, et al.
Journal of Cellular and Molecular Medicine|July 16, 2008
A pro-inflammatory signature mediates FGF2-induced angiogenesisGermán Andrés, Daria Leali, Stefania Mitola, et al.
Computational and Structural Biotechnology Journal|April 10, 2024
Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryosJessica Guerra, Mirella Belleri, Giulia Paiardi, et al.
Cancer Letters|December 3, 2021
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancerPaola Chiodelli, Daniela Coltrini, Marta Turati, et al.
The Journal of Biological Chemistry|October 17, 2008
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1Salvatore Ponticelli, Daniela Marasco, Valeria Tarallo, et al.
Biochemistry|August 14, 2002
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitorsBenito Casu, Marco Guerrini, Annamaria Naggi, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
International Journal of Molecular Sciences|July 14, 2023
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma CellsDavide Capoferri, Paola Chiodelli, Marzia Corli, et al.
Molecular Cancer Therapeutics|October 17, 2013
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cellsRoberto Ronca, Emanuela Di Salle, Arianna Giacomini, et al.
Oncotarget|May 14, 2016
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonistElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Journal of Cellular and Molecular Medicine|July 25, 2009
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptideDaria Leali, Roberta Bianchi, Antonella Bugatti, et al.
Molecular Cancer Research : MCR|March 11, 2010
The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivoJo Vandercappellen, Sandra Liekens, Annelies Bronckaers, et al.
Journal of Cellular and Molecular Medicine|July 16, 2008
A pro-inflammatory signature mediates FGF2-induced angiogenesisGermán Andrés, Daria Leali, Stefania Mitola, et al.
Computational and Structural Biotechnology Journal|April 10, 2024
Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryosJessica Guerra, Mirella Belleri, Giulia Paiardi, et al.
Cancer Letters|December 3, 2021
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancerPaola Chiodelli, Daniela Coltrini, Marta Turati, et al.
The Journal of Biological Chemistry|October 17, 2008
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1Salvatore Ponticelli, Daniela Marasco, Valeria Tarallo, et al.
Biochemistry|August 14, 2002
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitorsBenito Casu, Marco Guerrini, Annamaria Naggi, et al.
Pageof 19